ArticleCureus2025
Splenic Infarcts in a 22-Year-Old Boxer With Acute Epstein-Barr Virus Infection Without a Predisposing Haematological Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Splenic infarction is a rare complication of Epstein-Barr virus (EBV) infectious mononucleosis, particularly in the absence of pre-existing haematological disease. We report a 22-year-old male with ulcerative colitis on azathioprine who presented with fever, sore throat, malaise, cervical lymphadenopathy and left upper quadrant pain. Imaging revealed splenomegaly with multiple wedge-shaped hypodense lesions consistent with splenic infarction. Laboratory investigations demonstrated marked lymphocytosis, reduced protein C, and a heterozygous Factor V Leiden mutation. EBV viral capsid antigen immunoglobulin M (IgM) was positive. The patient was managed conservatively with intravenous fluids, prophylactic anticoagulation and temporary suspension of azathioprine. Splenic infarction is an uncommon but important manifestation of EBV-associated infectious mononucleosis. Postulated mechanisms include rapid splenic enlargement, transient hypercoagulability, and immunological processes. Conservative management is appropriate in most cases. Clinicians should maintain a high index of suspicion for splenic infarction in patients with infectious mononucleosis who report left upper quadrant pain. Early diagnosis is essential to prevent complications such as splenic rupture, and patients must be counselled to avoid contact sports during recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.